Crossmark

Choosing the source of healthy controls for studies on myeloid malignancies: all bone marrow cells are created equal, but some are more equal than others

Crossref DOI link: https://doi.org/10.1186/s13287-023-03257-z

Published Online: 2023-03-08

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Rivière, Jennifer

Hock, Jennifer

Buck, Michèle C.

Hecker, Judith S.

Götze, Katharina S.

van der Garde, Mark https://orcid.org/0000-0002-7227-0056
Funding

Funding for this research was provided by:

Deutschen Konsortium für Translationale Krebsforschung (CHOICE)

José Carreras Leukämie-Stiftung (DJCLS R14/18)

Deutsche Forschungsgemeinschaft (SFB 1243 A09)

Technische Universität München
License Information

Text and Data Mining valid from 2023-03-08

Version of Record valid from 2023-03-08
More Information

Article History

Received: 19 April 2022

Accepted: 13 February 2023

First Online: 8 March 2023

Declarations

:

: All human materials used in this study was obtained after informed written consent by the donor and with approval of the ethics committee of the Technische Universität München. Project title: Analyse der klonalen Hierarchie in MDS und die Beteiligung der Nische an der Progression in eine sekundäre AML. Institutional approval committee: Ethics committee TUM, Prof. Dr. Georg Schmidt. Approval number: TUM 538/16. Date of approval: December 14, 2016.

: The authors declare no competing interests or other disclosures.

Document is current

Any future updates will be listed below